Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for PCVX

Stock Name	Vaxcyte Inc
Ticker	PCVX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92243G1085
LEI	254900M7NMHTGASX8D95

Show aggregate PCVX holdings

News associated with PCVX

Vaxcyte, Inc. (NASDAQ:PCVX) Receives $106.25 Average Price Target from Analysts: Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has received an average rating of “Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The […] - 2025-09-16 02:32:42
Swiss National Bank Has $8.21 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX): Swiss National Bank reduced its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 0.8% in the 1st quarter, HoldingsChannel reports. The fund owned 217,300 shares of the company’s stock after selling 1,700 shares during the period. Swiss National Bank’s holdings in Vaxcyte were worth $8,205,000 at the end of the most recent quarter. Several […] - 2025-08-17 05:55:01
Natixis Advisors LLC Decreases Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX): Natixis Advisors LLC lowered its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 5.7% during the first quarter, Holdings Channel reports. The institutional investor owned 14,649 shares of the company’s stock after selling 888 shares during the period. Natixis Advisors LLC’s holdings in Vaxcyte were worth $553,000 at the end of the […] - 2025-08-12 04:38:46
Analysts Forecast 12% Upside For JHML: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:29
KLP Kapitalforvaltning AS Buys 500 Shares of Vaxcyte, Inc. (NASDAQ:PCVX): KLP Kapitalforvaltning AS increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 2.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,000 shares of the company’s stock after purchasing an additional 500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Vaxcyte […] - 2025-07-29 06:16:55
Universal Beteiligungs und Servicegesellschaft mbH Buys 3,634 Shares of Vaxcyte, Inc. (NASDAQ:PCVX): Universal Beteiligungs und Servicegesellschaft mbH raised its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 3.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 107,317 shares of the company’s stock after buying an additional 3,634 shares during the quarter. Universal […] - 2025-07-29 05:22:57
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $136.50: Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month […] - 2025-07-28 02:30:52
New York State Common Retirement Fund Increases Holdings in Vaxcyte, Inc. (NASDAQ:PCVX): New York State Common Retirement Fund increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 190.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 137,440 shares of the company’s stock after purchasing an additional 90,145 shares during the quarter. New York […] - 2025-07-22 07:09:01
Principal Financial Group Inc. Has $17.73 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX): Principal Financial Group Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 52.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 469,561 shares of the company’s stock after acquiring an additional 160,622 shares during the period. […] - 2025-07-11 05:21:08
Calamos Advisors LLC Has $257,000 Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX): Calamos Advisors LLC decreased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 32.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 6,794 shares of the company’s stock after selling 3,201 shares during the period. Calamos Advisors LLC’s holdings in Vaxcyte were worth […] - 2025-07-08 05:46:54
Vaxcyte, Inc. (NASDAQ:PCVX) Holdings Lowered by Allspring Global Investments Holdings LLC: Allspring Global Investments Holdings LLC trimmed its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 43.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 335,990 shares of the company’s stock after selling 257,533 shares during the […] - 2025-07-04 05:06:38
Analysts Set Vaxcyte, Inc. (NASDAQ:PCVX) Price Target at $136.50: Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among […] - 2025-07-03 02:42:45
Analyzing Vaxcyte (NASDAQ:PCVX) & Genenta Science (NASDAQ:GNTA): Genenta Science (NASDAQ:GNTA – Get Free Report) and Vaxcyte (NASDAQ:PCVX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Volatility & Risk Genenta Science has a beta of […] - 2025-06-13 02:32:52
The Math Shows ESML Can Go To $48: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-05 07:20:56
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Rating of “Buy” from Brokerages: Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has earned an average recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts […] - 2025-06-05 02:32:50
Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM): Vaxcyte (NASDAQ:PCVX – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends. Risk and Volatility Vaxcyte has a beta of 1.27, […] - 2025-05-30 02:28:51
Millennium Management LLC Sells 21,857 Shares of Vaxcyte, Inc. (NASDAQ:PCVX): Millennium Management LLC lessened its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 7.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 276,578 shares of the company’s stock after selling 21,857 shares during the quarter. Millennium Management LLC owned approximately […] - 2025-05-21 05:46:50
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Dimensional Fund Advisors LP: Dimensional Fund Advisors LP increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 115.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 293,706 shares of the company’s stock after buying an additional 157,277 shares during the period. Dimensional Fund Advisors LP’s holdings in Vaxcyte were worth $24,043,000 at the end of the […] - 2025-05-07 05:22:50
Mariner LLC Has $487,000 Position in Vaxcyte, Inc. (NASDAQ:PCVX): Mariner LLC boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 27.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 5,947 shares of the company’s stock after buying an additional 1,290 shares during the period. Mariner LLC’s holdings in Vaxcyte were worth $487,000 as of its most recent filing with the Securities […] - 2025-05-02 05:10:52
Renaissance Technologies LLC Purchases Shares of 54,077 Vaxcyte, Inc. (NASDAQ:PCVX): Renaissance Technologies LLC acquired a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 54,077 shares of the company’s stock, valued at approximately $4,427,000. A number of other hedge funds and other institutional investors […] - 2025-04-22 05:03:18
ILCB's Holdings Imply 27% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-04 08:46:47
Norges Bank Acquires Shares of 1,100,286 Vaxcyte, Inc. (NASDAQ:PCVX): Norges Bank bought a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,100,286 shares of the company’s stock, valued at approximately $90,069,000. Norges Bank owned about 0.88% of Vaxcyte at the end of the most […] - 2025-04-03 05:36:54
Bank of America Lowers Vaxcyte (NASDAQ:PCVX) Price Target to $137.00: Vaxcyte (NASDAQ:PCVX – Get Free Report) had its price target reduced by research analysts at Bank of America from $157.00 to $137.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price objective would suggest a potential upside of 306.65% from the […] - 2025-04-03 04:24:52
Needham & Company LLC Has Lowered Expectations for Vaxcyte (NASDAQ:PCVX) Stock Price: Vaxcyte (NASDAQ:PCVX – Get Free Report) had its target price lowered by investment analysts at Needham & Company LLC from $140.00 to $90.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 167.14% from the […] - 2025-04-03 04:24:52
Monday's ETF Movers: FBT, XBI: In trading on Monday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Corcept Therapeutics, up about 83.2% and shares of Amgen, up about 2% on the - 2025-03-31 13:11:30
Proficio Capital Partners LLC Invests $2.92 Million in Vaxcyte, Inc. (NASDAQ:PCVX): Proficio Capital Partners LLC purchased a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 35,609 shares of the company’s stock, valued at approximately $2,915,000. Several other large investors have also recently added to or reduced their stakes in the company. Whipplewood Advisors […] - 2025-03-19 05:44:45
PNC Financial Services Group Inc. Boosts Stake in Vaxcyte, Inc. (NASDAQ:PCVX): PNC Financial Services Group Inc. increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 18.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,076 shares of the company’s stock after acquiring an additional 1,397 shares during the period. PNC Financial Services Group Inc.’s holdings […] - 2025-03-18 05:38:57
Victory Capital Management Inc. Has $24.85 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX): Victory Capital Management Inc. lifted its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 19.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 303,556 shares of the company’s stock after purchasing an additional 48,516 shares during the quarter. Victory Capital Management Inc. owned […] - 2025-03-11 06:16:48
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $127.71: Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the company, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […] - 2025-02-28 04:06:48
After-Hours Earnings Report for February 25, 2025 : INTU, WDAY, ALC, CPNG, AXON, EXR, KEYS, FSLR, CART, CAVA, PCVX, PR: The following companies are expected to report earnings after hours on 02/25/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Intuit Inc. (INTU)is reporting for the quarter ending January 31, 2025. The computer software company's consensus earnings - 2025-02-25 17:00:00

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) PCVX holdings

Date	Number of PCVX Shares Held	Base Market Value of PCVX Shares	Local Market Value of PCVX Shares	Change in PCVX Shares Held	Change in PCVX Base Value	Current Price per PCVX Share Held	Previous Price per PCVX Share Held
2025-11-11 (Tuesday)	84,123	USD 3,841,056	USD 3,841,056	0	USD 230,497	USD 45.66	USD 42.92
2025-11-10 (Monday)	84,123	USD 3,610,559	USD 3,610,559	215	USD 115,791	USD 42.92	USD 41.65
2025-11-07 (Friday)	83,908	USD 3,494,768	USD 3,494,768	0	USD -5,035	USD 41.65	USD 41.71
2025-11-06 (Thursday)	83,908	USD 3,499,803	USD 3,499,803	215	USD 125,301	USD 41.71	USD 40.32
2025-11-05 (Wednesday)	83,693	USD 3,374,502	USD 3,374,502	0	USD -86,204	USD 40.32	USD 41.35
2025-11-04 (Tuesday)	83,693	USD 3,460,706	USD 3,460,706	216	USD -114,614	USD 41.35	USD 42.83
2025-11-03 (Monday)	83,477	USD 3,575,320	USD 3,575,320	0	USD -204,519	USD 42.83	USD 45.28
2025-10-31 (Friday)	83,477	USD 3,779,839	USD 3,779,839	0	USD 44,243	USD 45.28	USD 44.75
2025-10-30 (Thursday)	83,477	USD 3,735,596	USD 3,735,596	1,080	USD 149,679	USD 44.75	USD 43.52
2025-10-29 (Wednesday)	82,397	USD 3,585,917	USD 3,585,917	432	USD -67,263	USD 43.52	USD 44.57
2025-10-28 (Tuesday)	81,965	USD 3,653,180	USD 3,653,180	0	USD 0	USD 44.57	USD 44.57
2025-10-27 (Monday)	81,965	USD 3,653,180	USD 3,653,180	0	USD 191,798	USD 44.57	USD 42.23

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PCVX by Blackrock for IE00BDZVHG35

Show aggregate share trades of PCVX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 215 43.670 41.435 41.659 USD 8,957 58.25
2025-11-06 BUY 215 42.030 40.160 40.347 USD 8,675 58.43
2025-11-04 BUY 216 43.216 40.790 41.033 USD 8,863 58.62
2025-10-30 BUY 1,080 45.690 43.040 43.305 USD 46,769 58.86
2025-10-29 BUY 432 43.520 45.130 44.969 USD 19,427 58.95
2025-10-22 SELL -864 42.510 43.400 43.311 USD -37,421 59.40 Profit of 13,904 on sale
2025-10-20 BUY 432 42.900 43.300 43.260 USD 18,688 59.60
2025-10-17 BUY 1,079 42.390 43.910 43.758 USD 47,215 59.70
2025-10-15 BUY 1,720 43.940 45.130 45.011 USD 77,419 59.79
2025-10-03 BUY 1,498 42.660 43.120 43.074 USD 64,525 60.00
2025-10-02 BUY 214 40.130 40.240 40.229 USD 8,609 60.12
2025-09-30 BUY 428 36.020 36.575 36.520 USD 15,630 60.40
2025-09-26 BUY 428 33.980 34.110 34.097 USD 14,594 60.72
2025-09-25 BUY 428 32.140 32.900 32.824 USD 14,049 60.90
2025-09-18 BUY 223 32.590 32.840 32.815 USD 7,318 61.08
2025-09-17 BUY 672 30.885 33.160 32.932 USD 22,131 61.27
2025-07-17 SELL -446 37.370 37.920 37.865 USD -16,888 61.94 Profit of 10,738 on sale
2025-07-16 BUY 762 36.570 36.790 36.768 USD 28,017 62.11
2025-07-11 SELL -1,768 35.930 36.140 36.119 USD -63,858 62.63 Profit of 46,865 on sale
2025-07-02 BUY 12,155 33.270 34.415 34.301 USD 416,923 63.39
2025-06-25 BUY 442 33.090 34.120 34.017 USD 15,036 64.24
2025-06-20 BUY 1,980 32.870 33.710 33.626 USD 66,579 64.91
2025-06-11 BUY 428 35.440 37.450 37.249 USD 15,943 66.52
2025-06-10 BUY 428 37.200 37.650 37.605 USD 16,095 66.75
2025-06-04 SELL -214 33.840 35.420 35.262 USD -7,546 67.72 Profit of 6,945 on sale
2025-04-23 BUY 214 33.160 34.400 34.276 USD 7,335 78.41
2025-04-10 SELL -1,712 28.040 30.480 30.236 USD -51,764 83.27 Profit of 90,786 on sale
2025-04-08 SELL -214 30.200 33.750 33.395 USD -7,147 84.48 Profit of 10,932 on sale
2025-04-07 SELL -214 32.510 34.110 33.950 USD -7,265 85.08 Profit of 10,942 on sale
2025-04-04 SELL -1,070 31.600 33.250 33.085 USD -35,401 85.71 Profit of 56,311 on sale
2025-04-01 BUY 1,242 32.230 37.920 37.351 USD 46,390 86.98
2025-03-21 BUY 4,399 74.660 76.610 76.415 USD 336,150 88.85
2025-03-14 SELL -3,136 74.370 75.040 74.973 USD -235,115 89.83 Profit of 46,583 on sale
2025-03-07 SELL -392 71.180 75.080 74.690 USD -29,278 91.24 Profit of 6,486 on sale
2025-03-04 SELL -196 70.240 72.365 72.152 USD -14,142 92.11 Profit of 3,911 on sale
2025-02-25 BUY 392 79.350 82.770 82.428 USD 32,312 93.54
2025-02-19 SELL -196 83.360 83.710 83.675 USD -16,400 94.41 Profit of 2,104 on sale
2025-02-13 BUY 588 83.840 86.445 86.184 USD 50,676 95.27
2025-02-12 BUY 196 85.420 86.680 86.554 USD 16,965 95.48
2025-02-11 BUY 784 85.130 85.503 85.466 USD 67,005 95.69
2025-01-02 BUY 292 83.300 84.800 84.650 USD 24,718 98.68
2024-12-30 SELL -179 81.990 82.210 82.188 USD -14,712 99.19 Profit of 3,043 on sale
2024-11-18 SELL -2,880 86.490 87.320 87.237 USD -251,243 108.16 Profit of 60,246 on sale
2024-11-08 SELL -192 106.670 107.305 107.242 USD -20,590 108.89 Profit of 316 on sale
2024-10-30 BUY 268 106.110 107.670 107.514 USD 28,814 111.98
2024-10-21 SELL -191 115.450 115.970 115.918 USD -22,140 0.00 Loss of -22,140 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	215	43.670	41.435	41.659	USD 8,957	58.25
2025-11-06	BUY	215	42.030	40.160	40.347	USD 8,675	58.43
2025-11-04	BUY	216	43.216	40.790	41.033	USD 8,863	58.62
2025-10-30	BUY	1,080	45.690	43.040	43.305	USD 46,769	58.86
2025-10-29	BUY	432	43.520	45.130	44.969	USD 19,427	58.95
2025-10-22	SELL	-864	42.510	43.400	43.311	USD -37,421	59.40 Profit of 13,904 on sale
2025-10-20	BUY	432	42.900	43.300	43.260	USD 18,688	59.60
2025-10-17	BUY	1,079	42.390	43.910	43.758	USD 47,215	59.70
2025-10-15	BUY	1,720	43.940	45.130	45.011	USD 77,419	59.79
2025-10-03	BUY	1,498	42.660	43.120	43.074	USD 64,525	60.00
2025-10-02	BUY	214	40.130	40.240	40.229	USD 8,609	60.12
2025-09-30	BUY	428	36.020	36.575	36.520	USD 15,630	60.40
2025-09-26	BUY	428	33.980	34.110	34.097	USD 14,594	60.72
2025-09-25	BUY	428	32.140	32.900	32.824	USD 14,049	60.90
2025-09-18	BUY	223	32.590	32.840	32.815	USD 7,318	61.08
2025-09-17	BUY	672	30.885	33.160	32.932	USD 22,131	61.27
2025-07-17	SELL	-446	37.370	37.920	37.865	USD -16,888	61.94 Profit of 10,738 on sale
2025-07-16	BUY	762	36.570	36.790	36.768	USD 28,017	62.11
2025-07-11	SELL	-1,768	35.930	36.140	36.119	USD -63,858	62.63 Profit of 46,865 on sale
2025-07-02	BUY	12,155	33.270	34.415	34.301	USD 416,923	63.39
2025-06-25	BUY	442	33.090	34.120	34.017	USD 15,036	64.24
2025-06-20	BUY	1,980	32.870	33.710	33.626	USD 66,579	64.91
2025-06-11	BUY	428	35.440	37.450	37.249	USD 15,943	66.52
2025-06-10	BUY	428	37.200	37.650	37.605	USD 16,095	66.75
2025-06-04	SELL	-214	33.840	35.420	35.262	USD -7,546	67.72 Profit of 6,945 on sale
2025-04-23	BUY	214	33.160	34.400	34.276	USD 7,335	78.41
2025-04-10	SELL	-1,712	28.040	30.480	30.236	USD -51,764	83.27 Profit of 90,786 on sale
2025-04-08	SELL	-214	30.200	33.750	33.395	USD -7,147	84.48 Profit of 10,932 on sale
2025-04-07	SELL	-214	32.510	34.110	33.950	USD -7,265	85.08 Profit of 10,942 on sale
2025-04-04	SELL	-1,070	31.600	33.250	33.085	USD -35,401	85.71 Profit of 56,311 on sale
2025-04-01	BUY	1,242	32.230	37.920	37.351	USD 46,390	86.98
2025-03-21	BUY	4,399	74.660	76.610	76.415	USD 336,150	88.85
2025-03-14	SELL	-3,136	74.370	75.040	74.973	USD -235,115	89.83 Profit of 46,583 on sale
2025-03-07	SELL	-392	71.180	75.080	74.690	USD -29,278	91.24 Profit of 6,486 on sale
2025-03-04	SELL	-196	70.240	72.365	72.152	USD -14,142	92.11 Profit of 3,911 on sale
2025-02-25	BUY	392	79.350	82.770	82.428	USD 32,312	93.54
2025-02-19	SELL	-196	83.360	83.710	83.675	USD -16,400	94.41 Profit of 2,104 on sale
2025-02-13	BUY	588	83.840	86.445	86.184	USD 50,676	95.27
2025-02-12	BUY	196	85.420	86.680	86.554	USD 16,965	95.48
2025-02-11	BUY	784	85.130	85.503	85.466	USD 67,005	95.69
2025-01-02	BUY	292	83.300	84.800	84.650	USD 24,718	98.68
2024-12-30	SELL	-179	81.990	82.210	82.188	USD -14,712	99.19 Profit of 3,043 on sale
2024-11-18	SELL	-2,880	86.490	87.320	87.237	USD -251,243	108.16 Profit of 60,246 on sale
2024-11-08	SELL	-192	106.670	107.305	107.242	USD -20,590	108.89 Profit of 316 on sale
2024-10-30	BUY	268	106.110	107.670	107.514	USD 28,814	111.98
2024-10-21	SELL	-191	115.450	115.970	115.918	USD -22,140	0.00 Loss of -22,140 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PCVX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	204,246	81	702,291	29.1%
2025-09-18	247,318	147	1,182,122	20.9%
2025-09-17	478,618	0	1,628,296	29.4%
2025-09-16	258,632	0	784,301	33.0%
2025-09-15	193,594	318	494,380	39.2%
2025-09-12	262,307	0	527,659	49.7%
2025-09-11	181,619	0	473,839	38.3%
2025-09-10	278,938	6	810,108	34.4%
2025-09-09	197,276	1,000	484,764	40.7%
2025-09-08	356,154	300	666,464	53.4%
2025-09-05	251,668	0	581,150	43.3%
2025-09-04	288,827	4,175	579,054	49.9%
2025-09-03	282,305	0	622,626	45.3%
2025-09-02	220,320	0	734,357	30.0%
2025-08-29	107,976	0	267,835	40.3%
2025-08-28	260,554	0	594,666	43.8%
2025-08-27	179,746	0	724,103	24.8%
2025-08-26	114,100	0	664,628	17.2%
2025-08-25	196,846	0	900,657	21.9%
2025-08-22	120,850	0	342,735	35.3%
2025-08-21	153,745	120	483,243	31.8%
2025-08-20	118,380	0	353,360	33.5%
2025-08-19	113,550	0	325,277	34.9%
2025-08-18	156,869	0	446,083	35.2%
2025-08-15	144,453	1,997	521,835	27.7%
2025-08-14	214,706	0	564,088	38.1%
2025-08-13	219,025	67	1,278,221	17.1%
2025-08-12	247,228	89	705,279	35.1%
2025-08-11	233,662	136	622,096	37.6%
2025-08-08	117,171	10,841	1,145,858	10.2%
2025-08-07	318,955	20,887	1,174,518	27.2%
2025-08-06	125,483	0	261,571	48.0%
2025-08-05	114,223	106	238,075	48.0%
2025-08-04	100,205	0	238,748	42.0%
2025-08-01	140,190	2,064	321,077	43.7%
2025-07-31	128,745	0	378,867	34.0%
2025-07-30	138,630	0	351,934	39.4%
2025-07-29	181,456	445	398,378	45.5%
2025-07-28	128,910	69	541,006	23.8%
2025-07-25	143,535	100	357,219	40.2%
2025-07-24	112,578	199	342,450	32.9%
2025-07-23	116,822	100	187,700	62.2%
2025-07-22	162,681	225	214,667	75.8%
2025-07-21	255,787	100	321,419	79.6%
2025-07-18	262,894	66	397,878	66.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE